Role of the proximal enhancer of the major immediate-early promoter in human cytomegalovirus replication

被引:59
作者
Isomura, H
Tsurumi, T
Stinski, MF
机构
[1] Univ Iowa, Carver Coll Med, Dept Microbiol, Iowa City, IA 52242 USA
[2] Aichi Canc Ctr, Res Inst, Div Virol, Chikusa Ku, Nagoya, Aichi 464, Japan
关键词
D O I
10.1128/JVI.78.23.12788-12799.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The human cytomegalovirus (CMV) enhancer has a distal component (positions -550 to -300) and a proximal component (-300 to -39) relative to the transcription start site (+ 1) of the major immediate-early (MIE) promoter. Without the distal enhancer, human CMV replicates slower and has a small-plaque phenotype. We determined the sequence requirements of the proximal enhancer by making 5'-end deletions to positions -223, -173, -116, -67, and -39. Even though recombinant virus with the proximal enhancer deleted to -39 has the minimal TATA box-containing MIE promoter element, it cannot replicate independently in human fibroblast cells. Recombinant virus with a deletion to -67 has an Sp-1 transcription factor binding site which may represent a minimal enhancer element for recombinant virus replication in human fibroblast cells. Although recombinant virus with a deletion to -223 replicates to titers at least 100-fold less than that of the wild-type virus, it replicates to titers 8-fold higher than that of recombinant virus with a deletion to - 173 and 20-fold higher than that of virus with a deletion to -67. Recombinant virus with a deletion to -173 replicates more efficiently than that with a deletion to -116. There was a direct correlation between the level of infectious virus replication and time after infection, amount of MIE gene transcription, MIE and early viral protein synthesis, and viral DNA synthesis. The extent of the proximal enhancer determines the efficiency of viral replication.
引用
收藏
页码:12788 / 12799
页数:12
相关论文
共 61 条
[1]   The human cytomegalovirus IE2 and UL112-113 proteins accumulate in viral DNA replication compartments that initiate from the periphery of promyelocytic leukemia protein-associated nuclear bodies (PODs or ND10) [J].
Ahn, JH ;
Jang, WJ ;
Hayward, GS .
JOURNAL OF VIROLOGY, 1999, 73 (12) :10458-10471
[2]   Enhancer requirement for murine cytomegalovirus growth and genetic complementation by the human cytomegalovirus enhancer [J].
Angulo, A ;
Messerle, M ;
Kozinowski, UH ;
Ghazal, P .
JOURNAL OF VIROLOGY, 1998, 72 (11) :8502-8509
[3]   Neutrality of the canonical NF-κB-dependent pathway for human and murine cytomegalovirus transcription and replication in vitro [J].
Benedict, CA ;
Angulo, A ;
Patterson, G ;
Ha, SW ;
Huang, H ;
Messerle, M ;
Ware, CF ;
Ghazal, P .
JOURNAL OF VIROLOGY, 2004, 78 (02) :741-750
[4]   A subset of viral transcripts packaged within human cytomegalovirus particles [J].
Bresnahan, WA ;
Shenk, T .
SCIENCE, 2000, 288 (5475) :2373-2376
[5]  
BRITT WJ, 1996, FIELDS VIROLOGY, P2493
[6]   A HUMAN CYTOMEGALO-VIRUS EARLY GENE HAS 3 INDUCIBLE PROMOTERS THAT ARE REGULATED DIFFERENTIALLY AT VARIOUS TIMES AFTER INFECTION [J].
CHANG, CP ;
MALONE, CL ;
STINSKI, MF .
JOURNAL OF VIROLOGY, 1989, 63 (01) :281-290
[7]   HUMAN CYTOMEGALOVIRUS IE2 NEGATIVELY REGULATES ALPHA-GENE EXPRESSION VIA A SHORT TARGET SEQUENCE NEAR THE TRANSCRIPTION START SITE [J].
CHERRINGTON, JM ;
KHOURY, EL ;
MOCARSKI, ES .
JOURNAL OF VIROLOGY, 1991, 65 (02) :887-896
[8]   Vernal keratoconjunctivitis [J].
Colby, K ;
Dohlman, C .
INTERNATIONAL OPHTHALMOLOGY CLINICS, 1996, 36 (01) :15-20
[9]   Human cytomegalovirus activates inflammatory cytokine responses via CD14 and toll-like receptor 2 [J].
Compton, T ;
Kurt-Jones, EA ;
Boehme, KW ;
Belko, J ;
Latz, E ;
Golenbock, DT ;
Finberg, RW .
JOURNAL OF VIROLOGY, 2003, 77 (08) :4588-4596
[10]   Functional profiling of a human cytomegalovirus genome [J].
Dunn, W ;
Chou, C ;
Li, H ;
Hai, R ;
Patterson, D ;
Stolc, V ;
Zhu, H ;
Liu, FY .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (24) :14223-14228